MXD3 and lung adenocarcinoma: However, overexpression of MXD3 was associated with shorter survival of prostate adenocarcinoma (PRAD), mesothelioma (MESO), LGG, KICH, uveal melanoma (UVM), lung adenocarcinoma (LUAD), KIRC, ACC, THYM, HNSC, LICH, and glioblastoma multiforme (GBM) (Fig. 3D).